Probiotics for the treatment of acute diarrhea

Lactobacillus reuteri DSM 17938 for the treatment of acute diarrhea in children

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20201005005

Enrollment

Registered

2020-10-05

Start date

2020-10-26

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with acute diarrhea child diarrhea Lactobacillus reuteri probiotics

Interventions

Children one month&#45

5 years of age who presented with acute diarrhea will randomly assiged to receive a matching placebo which is identical in appearance ans texture to the intervention group. ,Children one month&#45

5 years of age who presented with acute diarrhea will randomly assiged to receive L. reuteri DSM 17928 at a dose of 100&#44

000&#44

000 colony&#45

forming units once daily for 5 days.

Placebo Comparator No treatment,Active Comparator Drug

control,Probiotic group

Eligibility

Sex/Gender

All

Age

1 Months to 5 Years

Inclusion criteria

Inclusion criteria: Children aged 1 moth-5 years presented with acute diarrhea

Exclusion criteria

Exclusion criteria: 1. Major systemic illness 2. commence on antibiotics 2 weeks prior to the study 3. received probiotics or anti-diarrheal drugs 2 weeks prior to the study 4. severe malnutrition

Design outcomes

Primary

Measure	Time frame
diarrhea at the end of intervention duration of diarrhea	—

Secondary

Measure	Time frame
severity of diarrhea at the end of study hospitalization	—

Countries

Thailand

Contacts

Public ContactSanguansak Rerksuppaphol

Srinakharinwirot University

sanguansak_r@hotmail.com0817231766

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026